Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/6/2003

PHARMANIAGA BERHAD

Quarterly report for the financial period ended

30/06/2003
Quarter2
Financial Year End31/12/2003
The figureshave not been audited

Attachments

pharma_klse0306.doc
209 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/06/2003


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
30/06/2003 
30/06/2002 
30/06/2003 
30/06/2002 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
155,262
157,420
309,787
298,096
2Profit/(loss) before tax
13,347
16,866
31,260
30,358
3Profit/(loss)
after tax and minority
interest
8,389
11,147
20,035
18,489
4Net profit/(loss) for
the period
8,389
11,147
20,035
18,489
5Basic earnings/(loss) per share (sen)
8.40
11.10
20.00
18.50
6Dividend per share (sen)
0.00
0.00
0.00
0.00



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR
END
7
Net tangible assets per share (RM)

1.9500
1.8000

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
The Board of Directors of Pharmaniaga Berhad recommends an interim tax exempt dividend of 3.5 sen per share for the current financial period ended 30 June 2003. (2002: tax exempt dividend of 2.5 sen per share)
The date of the book closure will be announced in due course.


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced19 Aug 2003  
CategoryFinancial Results
Reference NoCR-030819-51193